1. Reversal by insulin treatment of abnormal growth hormone pattern in newly diagnosed diabetes mellitus;CORRAL, R.J.; HUNTER, W.M.; CAMPBELL, I.W.; HARROWER, A.D.B.; DUNCAN, L.J.P.; CLARKE, B.F.;Acta endocrinologica,1974
2. Pituitary gland ablation by yttrium 90 implantation for advancing diabetic retinopathy;CULLEN, J.F.; GIBSON, P.F.; MACCUISH, A.C.; HARRIS, P.; DONALDSON, A.A.; MUNRO, J.F.; DUNCAN, L.J.P.;British Journal of Ophthalmology,1971
3. Abnormal TSH prolactin and growth hormone response to thyrotrophin-releasing factor in chronic renal failure;CZERNICHOW, P.; DAUZET, M.C.; BROYER, M.; RAPPAPORT, R.;Journal of Clinical Endocrinology; The suppressive effect of TRH on L-dopa promoted growth hormone release in healthy subjects and juvenile diabetics,1976
4. Hypothalamic hormone interaction in acromegaly;GOMEZ-PAN, A.; TUNBRIDGE, W.M.G.; DUNS, A.; HALL, R.; BESSER, G.M.; COY, D.H.; SCHALLY, A.V.; KASTIN, A.J.;Clinical Endocrinology,1975
5. Response to TRH in patients with renal failure and after infusion in normal man;GONZALEZ-BARCENA, D.; KASTIN, A.J.; SHALCH, D.S.; TORRES-ZAMARA, M.; PEREZ-PASTEN, E.; KATO, A.; SCHALLY, A.V.;Journal of Clinical Endocrinology,1973